Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$3.87 USD
+0.27 (7.50%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $3.88 +0.01 (0.26%) 7:58 PM ET
1-Strong Buy of 5 1
C Value C Growth A Momentum B VGM
Company Summary
Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.
Company Summary
General Information
Fulcrum Therapeutics, Inc
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Phone: 617-651-8851
Fax: NA
Email: ir@fulcrumtx.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 9/30/2024 |
Exp Earnings Date | 11/5/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.40 |
Current Year EPS Consensus Estimate | -0.28 |
Estimated Long-Term EPS Growth Rate | 57.70 |
Exp Earnings Date | 11/5/2024 |